ask="N/A"
ask_size="N/A"
average_daily_volume="15960"
bid="N/A"
bid_size="N/A"
book_value="0.34"
change="+0.25"
change_from_200_day_moving_average="0.68"
change_from_50_day_moving_average="0.32"
change_from_52_week_high="-2.00"
change_From_52_week_low="2.85"
change_in_percent="+4.39%"
close="5.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.42"
ebitda="-10.75M"
eps_estimate_current_year="-0.48"
eps_estimate_next_quarter="-0.11"
eps_estimate_next_year="-0.51"
ex_dividend_date="N/A"
float_shares="2879000"
high="6.05"
high_52_weeks="7.95"
last_trade_date="3/2/2017"
last_trade_price="5.95"
last_trade_size="100"
last_trade_time="4:45pm"
low="5.74"
low_52_weeks="3.10"
market_capitalization="170.98M"
moving_average_200_day="5.27"
moving_average_50_day="5.63"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="8.38"
open="5.74"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+12.82%"
percent_change_from_50_day_moving_average="+5.68%"
percent_change_from_52_week_high="-25.16%"
percent_change_from_52_week_low="+91.94%"
previous_close="5.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="16.62"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28736000"
short_ratio="4.26"
stock_exchange="ASE"
symbol="OCX"
volume="4823"
weeks_range_52="3.10 - 7.95"
